BT, Intercede and Imagination collaborate on IoT security
Jun 12, 2017 07:02 am UTC| Business
LONDON, June 12, 2017 -- Global technology company Imagination and digital identity and credentials expert Intercede are showcasing a solution for enhanced Internet of Things (IoT) security at BT’s bi-annual Innovation...
Jun 12, 2017 07:01 am UTC| Business
Nokia's optical network terminal (ONT) home gateway supports China Mobile's intelligent home servicesNokia home gateway deployed in fiber networks in 29 provinces across China Espoo, Finland - Nokia and China...
Secondary cone crusher, additional assays, and AA machine update for the Santa Elena mine
Jun 12, 2017 07:01 am UTC| Business
CABORCA, Mexico, June 12, 2017 -- Mexus Gold US (OTCQB:MXSG) (“Mexus” or the “Company”) announced today that the secondary cone crusher has arrived at the Santa Elena mine. This equipment will help the company and our...
Zealand to regain control of elsiglutide
Jun 12, 2017 06:49 am UTC| Business
Zealand to regain control of elsiglutide Helsinn returns elsiglutide to Zealand Zealand now has full rights to develop products within cancer-supportive care Lugano, Switzerland and Copenhagen, Denmark, June...
Alibaba breaks new highs, valued at US$360 billion, says Tokai National Partners
Jun 12, 2017 06:06 am UTC| Business
TORONTO, June 12, 2017 -- Tokai National Partners has released an online report on “Alibaba” after commenting on its increased valuation standing at over US$360 billion. Alibaba Group Holding is, without doubt, the...
Jun 12, 2017 05:17 am UTC| Business
The Adult Brain Tumor Consortium (ABTC) is designed to develop more effective treatments for malignant brain tumors. It is funded by the US National Cancer Institute (NCI). The ABTC will conduct a clinical phase 1 study to...
TiGenix announces final equity payment for cardiac platform acquisition
Jun 12, 2017 05:01 am UTC| Business
PRESS RELEASEregulated information Leuven (BELGIUM) - June 12, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory...